| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |